Bottom line
EMPTX vs UEMPX: the short answer
EMPTX and UEMPX are two share classes of the same fund — UBS Emerging Markets Equity Opportunity Fund — so they hold the identical portfolio. The differences are cost, minimums and how you buy them.
EMPTX is cheaper at 0.26% vs 1% — a difference of $74 a year per $10,000 invested.
Over five years, EMPTX returned +1.7% a year vs +0.9% for UEMPX.
Updated Nov 19, 2026
EMPTX vs UEMPX side by side
| EMPTX | UEMPX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Ubs | Ubs |
| Category | Emerging Markets | Emerging Markets |
| Expense ratio | 0.26% | 1% |
| Annual cost per $10k | $26 | $100 |
| 10-yr cost on $10k (prospectus) | $1,382 | $1,437 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +43.8% | +42.7% |
| 5-yr return (annualized) | +1.7% | +0.9% |
| 10-yr return (annualized) | — | — |
| Best quarter | +22.6% | +22.6% |
| Worst quarter | −23.3% | −23.3% |
| Net assets (fund) | $463.8M | $463.8M |
| Number of holdings | 40 | 40 |
| Portfolio turnover | 43% | 43% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | EMPTX | UEMPX | Difference |
|---|---|---|---|
| 2025 | +43.8% | +42.7% | +1.1% |
| 2024 | +2.5% | +1.8% | +0.8% |
| 2023 | +8.9% | +8.2% | +0.8% |
| 2022 | −25.4% | −26.0% | +0.6% |
| 2021 | −9.2% | −10.0% | +0.8% |
| 2020 | +24.8% | +23.8% | +1.0% |
Source: Fund prospectus bar charts
FAQ
What is the difference between EMPTX and UEMPX?
EMPTX and UEMPX are two share classes of the same fund — UBS Emerging Markets Equity Opportunity Fund — so they hold the identical portfolio. The differences are cost, minimums and how you buy them. EMPTX is cheaper at 0.26% vs 1% — a difference of $74 a year per $10,000 invested.
Which is cheaper, EMPTX or UEMPX?
EMPTX has the lower expense ratio (0.26%).
Should I own both EMPTX and UEMPX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.